BOHEMIA, N.Y., Nov. 30 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer and marketer of nutritional supplements, today announced that Michael Slade, its Senior Vice President and a member of the Board of Directors and trustee of a private charitable foundation, has adopted pre-arranged stock trading plans to sell a portion of his NBTY stock over time, as part of his individual long term strategy of asset diversification and to provide liquidity for the foundation. These stock trading plans were adopted in accordance with Rule 10b5-1 of the U.S. Securities Exchange Act of 1934 and NBTY's policies with respect to insider trading. Rule 10b5-1 allows corporate officers and directors to adopt written, pre- arranged stock trading plans when they do not have material, non-public information. Using these plans, insiders can diversify their investment portfolios and can avoid concerns about whether they had material, non-public information when they sold their stock. Under his Rule 10b5-1 plans, which are effective as of November 30, 2006, Mr. Slade may sell personally up to 250,000 shares and through the foundation up to 76,900 shares of NBTY stock over a period of approximately two years, starting in January 2007 and terminating in December 2008, subject to certain price targets and restrictions. If all of the stock eligible for sale under these plans is sold, Mr. Slade will still directly and indirectly own approximately 1.2 million shares or approximately 2% of NBTY's current outstanding stock. ABOUT NBTY NBTY is a leading vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R), Vitamin World(R), Puritan's Pride(R), Holland & Barrett(R), Rexall(R), Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R), American Health(R), GNC (UK)(R), DeTuinen(R), LeNaturiste(TM), SISU(R), Solgar(R) and Ester-C(R) brands. Contact: Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz & Co. President & Chief Financial Officer 212-725-4500 631-200-2020 DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil, President & Chief Financial Officer of NBTY, Inc., +1-631-200-2020; or Carl Hymans of G.S. Schwartz & Co., +1-212-725-4500, Web site: http://www.nbty.com/

Copyright

N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 N B T Y 차트를 더 보려면 여기를 클릭.
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 N B T Y 차트를 더 보려면 여기를 클릭.